Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-09-05
2006-09-05
Graser, Jennifer E. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S024100, C536S023100, C435S320100, C435S069100, C435S254200, C435S243000, C435S252300
Reexamination Certificate
active
07101990
ABSTRACT:
The use of nucleic acids and polypeptides which are involved in a pathway eventually leading to programmed cell death of yeast or fungi for the preparation of a medicament for treating diseases associated with yeast or fungi or for the treatment of prolifeative disorders or for preventing apoptosis in certain diseases is disclosed. Methods are provided to identify compounds which selectively modulate the expression or functionality of said polypeptides in the same or a parallel pathway. Also provided are compounds as well as pharmaceutical compositions, medicaments and vaccines. New nucleic acid sequences, probes and primers derived thereof, expression vectors and host cells transformed with said vectors, polypeptides and antibodies raised against said polypeptides are also disclosed.
REFERENCES:
patent: 2326413 (1998-12-01), None
patent: WO 9505750 (1995-03-01), None
patent: WO 9916787 (1999-04-01), None
patent: WO 9932514 (1999-07-01), None
patent: WO 0023083 (2000-04-01), None
patent: WO 0102550 (2001-01-01), None
Ligr, M. et al. “Mammatian Bax triggers apoptotic changes in yeast”. Federation of Biochemical Societies (FEBS) Letters 438 (1998) pp. 61-65. XP-000857722.
Marzo, I. et al. “Bax and Adenhe Nucleotide Translocaton Cooperate in the Mitochondrial Control of Apoptosis”. SCIENCE vol. 281, Sep. 25, 1998, pp. 2027-2031, XP-000982449.
Tao, W. et al. “Modulation of Cell Death in Yeast by the Bci-2 Family of Proteins”. Journal of Biological Chemistry 1997, vol. 272, Issue of Jun. 13, pp. 15547-15552, XP-000982450.
Greenhalf, W. et al. “A Secletion System for Human Apoptosis Inhibitors Using Yeast”. Oncology Research, Novartis Pharma AG, Basel, Switzerland. Yeast 15 (1999), pp. 1307-1321. XP-002174101.
Brown, A. et al. “Codon utilsation in the pathogenic yeast, Candida albicans”. Nucleic Acids Research, vol. 19, No. 15, Submitted May 28, 1991. p. 4298. Oxford University Press. XP-00100538. (Abstract).
Matsuyama, S. et al. “The Mitochondrial FOF1-ATPase Proton Pump Is Required for Function of the Prospoptotic Protein Bax in Yeast and Mammalian Cells”. Molecular Cell, vol. 1, pp. 327-336, Feb. 1998, XP-000987219.
Martinet, W. et al. “Bax-induced cell death in Pichia pastoris” Biotechnology Letters 21: pp. 821-829, 1999. XP-001106921.
Frohlich, K. et al. “Apoptosis in yeast—a monocellular organism exhibits atrulstic behaviour” FEBS Letters 473 (2000) pp. 6-9.
Oitvai, Z. et al. “Bci-2 Heterodimertzes in Vivo with a Conserved Homolog, Bax, That Accelerates Programmed Cell Death” Cell, vol. 74, pp. 609-619, Aug. 27, 1993. XP-002018918.
Torgler, C.N. et al. “Exploiting the utility of yeast in the context of programmed cell death”. Medthe Methods Enzymol 2000, 297-322, XP-002174102. (Abstract).
Xu, Q. et al. “Methods of Assaying Bci-2 and Bax Family Proteins in Yeast”. A Companion to Methods in Enzymology 17, pp. 292-304 (1999).
Contreras Roland Henri
Eberhardt Ines
Luyten Walter Herman Maria
Reekmans Rieka Josephina
Donnelly Laura
Graser Jennifer E.
Janssen Pharmaceutica N.V.
LandOfFree
Bax-responsive genes for drug target identification in yeast... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bax-responsive genes for drug target identification in yeast..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bax-responsive genes for drug target identification in yeast... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3576798